Researchers are combining experience in chemical synthesis and nanoparticle engineering with their knowledge of cancer development to design future therapies.
The FDA has expanded its approval of belzutifan, a new kidney cancer drug, to treat metastatic renal cancer. Learn about UT Southwestern's role, from gene discovery to drug development.
UT Southwestern is a leader in robotic surgery for breast, liver and pancreatic cancer removal. Learn how these procedures reduce complications and improve outcomes.